Citation Impact
Citing Papers
Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer
2009
Proliferation Markers Are Associated with MET Expression in Hepatocellular Carcinoma and Predict Tivantinib Sensitivity In Vitro
2017
Phase locking and multiple oscillating attractors for the coupled mammalian clock and cell cycle
2014
NONO couples the circadian clock to the cell cycle
2012
Epigenetic regulation of hypoxic sensing disrupts cardiorespiratory homeostasis
2012 StandoutNobel
Circadian oscillation of nucleotide excision repair in mammalian brain
2009 StandoutNobel
Loss of cryptochrome reduces cancer risk in p53 mutant mice
2009 StandoutNobel
Similar Nucleotide Excision Repair Capacity in Melanocytes and Melanoma Cells
2010 StandoutNobel
Linkage Map ofEscherichia coliK-12, Edition 10: The Traditional Map
1998
The LARK RNA-Binding Protein Selectively Regulates the Circadian Eclosion Rhythm by Controlling E74 Protein Expression
2007
SCF Fbxl3 Controls the Oscillation of the Circadian Clock by Directing the Degradation of Cryptochrome Proteins
2007 Science
Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia
2016
The Circadian Clock Component BMAL1 Is a Critical Regulator of p21 Expression and Hepatocyte Proliferation
2007
Cryptochrome, Circadian Cycle, Cell Cycle Checkpoints, and Cancer
2005 StandoutNobel
The NAD+-Dependent Deacetylase SIRT1 Modulates CLOCK-Mediated Chromatin Remodeling and Circadian Control
2008
A Large Scale shRNA Barcode Screen Identifies the Circadian Clock Component ARNTL as Putative Regulator of the p53 Tumor Suppressor Pathway
2009
The DNA-damage response in human biology and disease
2009 StandoutNature
EGFR Antagonists in Cancer Treatment
2008 Standout
Metabolism and cancer: the circadian clock connection
2009
Systems biology of neutrophil differentiation and immune response
2005
HCLK2 is essential for the mammalian S-phase checkpoint and impacts on Chk1 stability
2007
Modulation of ATR-mediated DNA damage checkpoint response by cryptochrome 1
2014
Inhibition of AP-1 by SARI negatively regulates transformation progression mediated by CCN1
2010 Standout
JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
2012 Standout
Cystic fibrosis
2016 Standout
Eicosapentaenoic Acid Demethylates a Single CpG That Mediates Expression of Tumor Suppressor CCAAT/Enhancer-binding Protein δ in U937 Leukemia Cells
2011
Phase Resetting of the Mammalian Circadian Clock by DNA Damage
2008
Roles of individual prolyl‐4‐hydroxylase isoforms in the first 24 hours following transient focal cerebral ischaemia: insights from genetically modified mice
2012 StandoutNobel
The SIN3A histone deacetylase complex is required for a complete transcriptional response to hypoxia
2017 StandoutNobel
Disrupting Circadian Homeostasis of Sympathetic Signaling Promotes Tumor Development in Mice
2010
Deficiency in PER proteins has no effect on the rate of spontaneous and radiation-induced carcinogenesis
2013
Pharmacological targeting of endoplasmic reticulum stress in disease
2021
Hallmarks of aging: An expanding universe
2023 Standout
Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
2015 StandoutNature
Circadian clocks and cell division
2010
PERIOD1 (PER1) has anti-apoptotic effects, and PER3 has pro-apoptotic effects during cisplatin (CDDP) treatment in human gingival cancer CA9-22 cells
2011
Gene Model 129 (Gm129) Encodes a Novel Transcriptional Repressor That Modulates Circadian Gene Expression
2014 StandoutNobel
Clk post-transcriptional control denoises circadian transcription both temporally and spatially
2015 StandoutNobel
Regulation of nucleotide excision repair activity by transcriptional and post-transcriptional control of the XPA protein
2010 StandoutNobel
Disruption of the mouse protein Ser/Thr phosphatase 2Cβ gene leads to early pre-implantation lethality
2007 StandoutNobel
Mammalian TIMELESS Is Involved in Period Determination and DNA Damage-Dependent Phase Advancing of the Circadian Clock
2013
Pharmacological Modulators of the Circadian Clock as Potential Therapeutic Drugs: Focus on Genotoxic/Anticancer Therapy
2013
The single-cell transcriptional landscape of mammalian organogenesis
2019 StandoutNature
Tel2 mediates activation and localization of ATM/Tel1 kinase to a double-strand break
2008 StandoutNobel
PERIOD1 is an Anti-apoptotic Factor in Human Pancreatic and Hepatic Cancer Cells
2009
PML regulates PER2 nuclear localization and circadian function
2012
Circadian clock control of the cellular response to DNA damage
2010 StandoutNobel
Sequencing thousands of single-cell genomes with combinatorial indexing
2017
Cooperativity of Stress-Responsive Transcription Factors in Core Hypoxia-Inducible Factor Binding Regions
2012
Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer
2011
EMT: 2016
2016 Standout
Circadian proteins in the regulation of cell cycle and genotoxic stress responses
2007
Neutrophils, from Marrow to Microbes
2010 Standout
Biochemical Analysis of the Canonical Model for the Mammalian Circadian Clock
2011 StandoutNobel
Clocks, Metabolism, and the Epigenome
2012
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
2017 Standout
Emerging links between the biological clock and the DNA damage response
2007
Human DNA Damage Checkpoint Protein hRAD9 Is a 3′ to 5′ Exonuclease
2000 StandoutNobel
Dual modes of CLOCK:BMAL1 inhibition mediated by Cryptochrome and Period proteins in the mammalian circadian clock
2014 StandoutNobel
Disruption of the circadian clock due to theClockmutation has discrete effects on aging and carcinogenesis
2008
The genetics of mammalian circadian order and disorder: implications for physiology and disease
2008
Inflammation, metaflammation and immunometabolic disorders
2017 StandoutNature
Comprehensive Integration of Single-Cell Data
2019 Standout
CLOCK:BMAL1 is a pioneer-like transcription factor
2014 StandoutNobel
CLOCK deubiquitylation by USP8 inhibits CLK/CYC transcription in Drosophila
2012 StandoutNobel
Defective Innate Immunity and Hyperinflammation in Newborn Cystic Fibrosis Transmembrane Conductance Regulator–Knockout Ferret Lungs
2014
Click Chemistry for Drug Development and Diverse Chemical–Biology Applications
2013 Standout
Modulation of DNA binding properties of CCAAT/enhancer binding protein epsilon by heterodimer formation and interactions with NFkappaB pathway
2007
C/EBPα Expression Is Downregulated in Human Nonmelanoma Skin Cancers and Inactivation of C/EBPα Confers Susceptibility to UVB-Induced Skin Squamous Cell Carcinomas
2011
Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis
2011 StandoutNobel
Circadian Proteins and Genotoxic Stress Response
2010
Disrupting the circadian clock: Gene-specific effects on aging, cancer, and other phenotypes
2011
Negative feedback control of HIF-1 through REDD1-regulated ROS suppresses tumorigenesis
2010
Endoplasmic Reticulum Stress in Immunity
2014
BMAL1-dependent regulation of the mTOR signaling pathway delays aging
2014
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
Bidirectional regulation between TMEFF2 and STAT3 may contribute to H elicobacter pylori‐associated gastric carcinogenesis
2014
Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms
2010
A Series of Potent and Selective, Triazolylphenyl-Based Histone Deacetylases Inhibitors with Activity against Pancreatic Cancer Cells and Plasmodium falciparum
2008
Functional tests of enhancer conservation between distantly related species
2003 StandoutNobel
Conserved regulation of the lymphocyte-specific expression oflckin the Fugu and mammals
2002 StandoutNobel
Circadian-independent cell mitosis in immortalized fibroblasts
2010
Control of skin cancer by the circadian rhythm
2011 StandoutNobel
Regulation of apoptosis by the circadian clock through NF-κB signaling
2011 StandoutNobel
Comparative Photochemistry of Animal Type 1 and Type 4 Cryptochromes
2009 StandoutNobel
New mutations and pathogenesis of myeloproliferative neoplasms
2011
Circadian Timing in Cancer Treatments
2010
The Role of Clock Genes in Pharmacology
2010
Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum
2011 StandoutScience
Systems Biology of Mammalian Circadian Clocks
2010
Circadian Clock, Cancer, and Chemotherapy
2014 StandoutNobel
Effect of circadian clock mutations on DNA damage response in mammalian cells
2012 StandoutNobel
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Nascent-Seq analysis of Drosophila cycling gene expression
2013 StandoutNobel
Circadian control of XPA and excision repair of cisplatin-DNA damage by cryptochrome and HERC2 ubiquitin ligase
2010 StandoutNobel
Interplay of Circadian Clocks and Metabolic Rhythms
2006
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
2009 StandoutScience
Restriction of DNA Replication to the Reductive Phase of the Metabolic Cycle Protects Genome Integrity
2007 Science
Molecular and Pathologic Aspects of Endometrial Carcinogenesis
2006
Works of Sigal Gery being referenced
A Role for the Clock Gene Per1 in Prostate Cancer
2009
Off-Target Effects of c-MET Inhibitors on Thyroid Cancer Cells
2013
Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (Vorinostat, SAHA) profoundly inhibits the growth of human pancreatic cancer cells
2007
C/EBPδ expression in a BCR-ABL-positive cell line induces growth arrest and myeloid differentiation
2005
HPP1‐mediated tumor suppression requires activation of STAT1 pathways
2007
RTP801 is a novel retinoic acid–responsive gene associated with myeloid differentiation
2007
Uniquely Conserved Non-translated Regions are Involved in Generation of the Two Major Transcripts of Protein Phosphatase 2Cβ
2001
The clock gene Per2 links the circadian system to the estrogen receptor
2007
Epigenetic regulation and molecular characterization of C/EBPα in pancreatic cancer cells
2008
TMEFF2 is an androgen-regulated gene exhibiting antiproliferative effects in prostate cancer cells
2002
Circadian rhythms and cancer
2010
Restoration of C/EBPα Expression in a BCR-ABL+ Cell Line Induces Terminal Granulocytic Differentiation
2003
Valosin-Containing Protein/p97 as a Novel Therapeutic Target in Acute Lymphoblastic Leukemia
2017
An Escherichia coli gene divergently transcribed from a promoter overlapping the metA promoter
2006
Transcription profiling of C/EBP targets identifies Per2 as a gene implicated in myeloid leukemia
2005
The Circadian Gene Per1 Plays an Important Role in Cell Growth and DNA Damage Control in Human Cancer Cells
2006
Abstract 510: Inhibition of IRE1α-driven pro-survival pathways is a promising therapeutic application in acute myeloid leukemia
2014
Epigenetic Silencing of the Candidate Tumor Suppressor Gene Per1 in Non–Small Cell Lung Cancer
2007
Down-Regulation and Growth Inhibitory Role of C/EBPα in Breast Cancer
2005
Discovery of Epigenetically Masked Tumor Suppressor Genes in Endometrial Cancer
2005
Adaptor protein Lnk negatively regulates the mutant MPL, MPLW515L associated with myeloproliferative disorders
2007
2013
Ovarian Carcinomas: CCN Genes Are Aberrantly Expressed and CCN1 Promotes Proliferation of these Cells
2005
Retinoic acid regulates C/EBP homologous protein expression (CHOP), which negatively regulates myeloid target genes
2004
C/EBPϵ interacts with retinoblastoma and E2F1 during granulopoiesis
2003